Jennison Associates’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.2M | Buy |
+715,467
| New | +$37.2M | 0.02% | 258 |
|
|
2024
Q3 | – | Sell |
-497,088
| Closed | -$14.4M | – | 582 |
|
|
2024
Q2 | $14.4M | Buy |
497,088
+7,431
| +2% | +$215K | 0.01% | 359 |
|
|
2024
Q1 | $10.1M | Buy |
489,657
+9,811
| +2% | +$202K | 0.01% | 397 |
|
|
2023
Q4 | $13M | Sell |
479,846
-1,411,038
| -75% | -$38.2M | 0.01% | 364 |
|
|
2023
Q3 | $56M | Buy |
1,890,884
+403,475
| +27% | +$12M | 0.05% | 162 |
|
|
2023
Q2 | $53.2M | Buy |
+1,487,409
| New | +$53.2M | 0.04% | 182 |
|
|
2022
Q1 | – | Sell |
-167,226
| Closed | -$16.7M | – | 661 |
|
|
2021
Q4 | $16.7M | Sell |
167,226
-509,718
| -75% | -$51M | 0.01% | 392 |
|
|
2021
Q3 | $84.6M | Sell |
676,944
-8,175
| -1% | -$1.02M | 0.05% | 135 |
|
|
2021
Q2 | $85.1M | Sell |
685,119
-2,043,552
| -75% | -$254M | 0.06% | 144 |
|
|
2021
Q1 | $417M | Sell |
2,728,671
-278,306
| -9% | -$42.5M | 0.3% | 54 |
|
|
2020
Q4 | $388M | Sell |
3,006,977
-170,468
| -5% | -$22M | 0.28% | 55 |
|
|
2020
Q3 | $355M | Sell |
3,177,445
-157,764
| -5% | -$17.6M | 0.29% | 51 |
|
|
2020
Q2 | $271M | Buy |
3,335,209
+737,024
| +28% | +$59.8M | 0.24% | 53 |
|
|
2020
Q1 | $181M | Sell |
2,598,185
-64,048
| -2% | -$4.46M | 0.22% | 59 |
|
|
2019
Q4 | $208M | Sell |
2,662,233
-713,456
| -21% | -$55.7M | 0.21% | 64 |
|
|
2019
Q3 | $215M | Buy |
3,375,689
+622,154
| +23% | +$39.7M | 0.23% | 59 |
|
|
2019
Q2 | $238M | Buy |
2,753,535
+2,068,098
| +302% | +$179M | 0.24% | 58 |
|
|
2019
Q1 | $52.6M | Sell |
685,437
-157,883
| -19% | -$12.1M | 0.05% | 213 |
|
|
2018
Q4 | $31.7M | Buy |
+843,320
| New | +$31.7M | 0.04% | 273 |
|